This is the idea. Why not ??? The thing is w
Post# of 148175
The thing is we need to incorporate them (or any other) as part of our trial protocol.
We are going "solo", which is fair enough but maybe a combo will have a more profound impact and therefore a higher chance of success.
Note: I am not saying LL is not beneficial, all I am sayin is the ultimate PASC therapeutics will be likely a combination of drugs where LL hopefully will be the leading one.